Features Why Covid-19 didn’t hurt tech brands’ appetite for Asian investment Comment Novartis aiming to expand patient reach for world’s most expensive drug, Zolgensma
Comment Boehringer’s BI 425809 hints at cognitive improvement in schizophrenia patients GlobalData Healthcare
Comment Arcutis presents topline Phase III roflumilast data at EADV spring 2021 GlobalData Healthcare
Comment Endometrial cancer patients expected to benefit from novel advancements in the market GlobalData Healthcare
Comment AAN 2021: Impel’s INP104 could restore underused nasal delivery for acute migraine GlobalData Healthcare
Comment Another domestic Chinese PD-1 inhibitor enters the race for US approval following Coherus BioSciences’ deal with Shanghai Junshi Biosciences GlobalData Healthcare
Comment Roche’s Ocrevus set to top $7.6bn in sales by 2028 backed by new dosing approval GlobalData Healthcare